Eye scans could reveal hidden clues to MS treatment success
NCT ID NCT06864936
Summary
This study aims to find new signs in eye scans that show how the multiple sclerosis (MS) drug ublituximab is working inside the body. Researchers will enroll 30 people with relapsing MS—half starting the drug and half on other stable treatments—and perform special eye scans over a year. The goal is to learn if these scans can provide a clearer picture of the drug's effects on the immune system.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Maryland, Baltimore
Baltimore, Maryland, 21201, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.